Advances have been made in the delivery of oligonucleotide drugs, with research focusing on various methods to improve their effectiveness. Studies are exploring the use of lipid nanoparticles, extracellular vesicles, and other technologies to enhance delivery across biological barriers, including the blood-brain barrier. The development of oligonucleotide therapeutics is an active area of research, with ongoing clinical trials and a growing pipeline of potential treatments.